Neuroprotective Effect of miR-483-5p Against Cardiac Arrest-Induced Mitochondrial Dysfunction Mediated Through the

Qiang Zhang1,2, Haohong Zhan3,2, Cong Liu1,2

  • 1Department of Emergency Medicine, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, China.

Insights

MicroRNAs (miRNAs) protect the brain after cardiac arrest. This study shows miR-483-5p enhances cell survival and reduces injury by regulating mitochondrial function and oxidative stress, offering a potential therapeutic target for postcardiac arrest brain injury.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Postcardiac arrest brain injury (PCABI) leads to significant morbidity and mortality.
  • MicroRNAs (miRNAs) are key regulators of neuronal metabolism and neurological injury.
  • Identifying prognostic miRNAs is crucial for understanding PCABI outcomes.

Purpose of the Study:

  • To identify miRNAs associated with neurological dysfunction prognosis after cardiopulmonary resuscitation (CPR).
  • To investigate the neuroprotective effects of miR-483-5p in ischemia-reperfusion injury.
  • To elucidate the mechanisms underlying miR-483-5p's action on mitochondrial function, apoptosis, and oxidative stress.

Main Methods:

  • Bioinformatic analysis of Gene Expression Omnibus (GEO) database for miRNA identification.
  • In vitro and in vivo experiments using PC12 cells and hippocampal samples.
  • Western blot analysis to assess protein expression and molecular pathway activation.

Main Results:

  • miR-483-5p was downregulated in PC12 cells and hippocampi post-ischemia-reperfusion.
  • Overexpression of miR-483-5p enhanced cell viability and reduced cell death.
  • miR-483-5p promoted mitochondrial biogenesis, inhibited apoptosis, and reduced oxidative stress by targeting TNFSF8 and regulating the AMPK/JNK pathway.

Conclusions:

  • miR-483-5p plays a significant neuroprotective role after CPR.
  • Targeting miR-483-5p offers a potential therapeutic strategy for mitigating neurological impairment in PCABI.
  • This study provides insights into novel therapeutic targets for PCABI.

Related Concept Videos